Richard Barry - 13 May 2025 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Director
Signature
/s/ Cristin Rothfuss, as Attorney-in-Fact for Richard Barry
Issuer symbol
SRPT
Transactions as of
13 May 2025
Net transactions value
+$389,359
Form type
4
Filing time
15 May 2025, 07:00:11 UTC
Previous filing
21 Apr 2025
Next filing
19 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Barry Richard Director 215 FIRST STREET, SUITE 415, CAMBRIDGE /s/ Cristin Rothfuss, as Attorney-in-Fact for Richard Barry 15 May 2025 0001562371

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Options Exercise $245,404 +9,746 +0.33% $25.18 2,943,817 13 May 2025 Direct
transaction SRPT Common Stock Options Exercise $143,955 +10,500 +0.36% $13.71 2,954,317 13 May 2025 Direct
holding SRPT Common Stock 240,000 13 May 2025 By Trust
holding SRPT Common Stock 10,000 13 May 2025 By LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRPT Stock Option (right to buy) Options Exercise $0 -9,746 -100% $0.000000 0 13 May 2025 Common Stock 9,746 $25.18 Direct
transaction SRPT Stock Option (right to buy) Options Exercise $0 -10,500 -100% $0.000000 0 13 May 2025 Common Stock 10,500 $13.71 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.